Advertisement
U.S. markets open in 7 hours 51 minutes

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
139.44+0.34 (+0.24%)
At close: 04:00PM EDT
139.51 +0.07 (+0.05%)
After hours: 07:15PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Inside Bar (Bearish)

Inside Bar (Bearish)

Previous Close139.10
Open139.25
Bid136.01 x 800
Ask140.50 x 800
Day's Range138.57 - 141.76
52 Week Range89.04 - 143.35
Volume654,478
Avg. Volume845,978
Market Cap13.875B
Beta (5Y Monthly)0.24
PE Ratio (TTM)56.45
EPS (TTM)2.47
Earnings DateMay 01, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 29, 1995
1y Target Est151.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
45% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NBIX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Neurocrine Biosciences, Inc.
    NBIX: Raising target price to $145.00NEUROCRINE BIOSCIENCES INC has an Investment Rating of HOLD; a target price of $145.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more